The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Adrenergic Receptor Blockade Reverses Right Heart Remodeling and Dysfunction in Pulmonary Hypertensive Rats
Abstract
RATIONALE: Most patients with pulmonary arterial hypertension (PAH) die from right heart failure. Beta-adrenergic receptor blockade reduces mortality by about 30% in patients with left-sided systolic heart failure, but is not used in PAH. OBJECTIVES: To assess the effect of the adrenergic receptor blocker carvedilol on the pulmonary circulation and right heart in experimental pulmonary hypertension in rats. METHODS: Angioproliferative pulmonary hypertension was induced in rats by combined exposure to the vascular endothelial growth factor-receptor antagonist SU5416 and hypoxia. Carvedilol treatment was started after establishment of pulmonary hypertension and right heart dysfunction. MEASUREMENTS AND MAIN RESULTS: Compared with vehicle-treated animals, treatment with carvedilol resulted in increased exercise endurance; improved right ventricular (RV) function (increased tricuspid annular plane systolic excursion and decreased RV dilatation); and an increased cardiac output. The morphology of the pulmonary vessels and the RV afterload were not affected by carvedilol. Carvedilol treatment was associated with enhancement of RV fetal gene reactivation, increased protein kinase G (PKG) activity, and a reduction in capillary rarefaction and fibrosis. Metoprolol had similar but less pronounced effects in the SU5416 and hypoxia model. Cardioprotective effects were noted of both carvedilol and metoprolol in the monocrotaline model. In the case of carvedilol, but not metoprolol, part of these effects resulted from a prevention of monocrotaline-induced lung remodeling. CONCLUSIONS: Adrenergic receptor blockade reverses RV remodeling and improves RV function in experimental pulmonary hypertension. Beta-adrenergic receptor blockers are not recommended in humans with PAH before their safety and efficacy are assessed in well-designed clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial
(1999) · The Lancet · doi:10.1016/s0140-6736(98)11181-9 · Cited by 4,929
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
Hunt, S. A. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.08.022 · Cited by 4,154
Authors/Task Force Members, Galie, N., Hoeper, M. M., Humbert, M., Torbicki, A., Vachiery, J.-L., Barbera, J. A., Beghetti, M., Corris, P., Gaine, S., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp297 · Cited by 3,846
D'Alonzo, G. E., Barst, R. J., Ayres, S. M., Bergofsky, E. H., Brundage, B. H., Detre, K. M., Fishman, A. P., Goldring, R. M., Groves, B. M., Kernis, J. T., et al. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-5-343 · Cited by 3,501
Effect of carvedilol on survival in severe chronic heart failure
Packer, M., Coats, A. J. S., Fowler, M. B., Katus, H. A., Krum, H., Mohacsi, P., Rouleau, J. L., Tendera, M., Castaigne, A., Roecker, E. B., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105313442201 · Cited by 3,093
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
McLaughlin, V. V., Archer, S. L., Badesch, D. B., Barst, R. J., Farber, H. W., Lindner, J. R., Mathier, M. A., McGoon, M. D., Park, M. H., Rosenson, R. S., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.01.004 · Cited by 2,360
Poole-Wilson, P. A., Swedberg, K., Cleland, J. G., Di Lenarda, A., Hanrath, P., Komajda, M., Lubsen, J., Lutiger, B., Metra, M., Remme, W. J., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13800-7 · Cited by 1,872
Hjalmarson, Å., Goldstein, S., Fagerberg, B., Wedel, H., Waagstein, F., Kjekshus, J., Wikstrand, J., El Allaf, D., Vítovec, J., Aldershvile, J., et al. (2000) · JAMA · doi:10.1001/jama.283.10.1295 · Cited by 1,399
Guidelines for the diagnosis and treatment of pulmonary hypertension
(2009) · European Respiratory Journal · doi:10.1183/09031936.00139009 · Cited by 1,300
TARASEVICIENE‐STEWART, L., KASAHARA, Y., ALGER, L., HIRTH, P., MAHON, G. M., WALTENBERGER, J., VOELKEL, N. F., & TUDER, R. M. (2001) · The FASEB Journal · doi:10.1096/fj.00-0343com · Cited by 817
Self-citationThe Right Ventricle Under Pressure
Bogaard, H. J., Abe, K., Vonk Noordegraaf, A., & Voelkel, N. F. (2009) · Chest · doi:10.1378/chest.08-0492 · Cited by 679
Self-citationA unique mechanism of β-blocker action: Carvedilol stimulates β-arrestin signaling
Wisler, J. W., DeWire, S. M., Whalen, E. J., Violin, J. D., Drake, M. T., Ahn, S., Shenoy, S. K., & Lefkowitz, R. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707936104 · Cited by 597
Nagendran, J., Archer, S. L., Soliman, D., Gurtu, V., Moudgil, R., Haromy, A., St. Aubin, C., Webster, L., Rebeyka, I. M., Ross, D. B., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.655266 · Cited by 530
Eisenmenger syndrome. Factors relating to deterioration and death
Daliento, L., Somerville, J., Presbitero, P., Menti, L., Brach-Prever, S., Rizzoli, G., & Stone, S. (1998) · European Heart Journal · doi:10.1053/euhj.1998.1046 · Cited by 526
Chronic Pulmonary Artery Pressure Elevation Is Insufficient to Explain Right Heart Failure
Bogaard, H. J., Natarajan, R., Henderson, S. C., Long, C. S., Kraskauskas, D., Smithson, L., Ockaili, R., McCord, J. M., & Voelkel, N. F. (2009) · Circulation · doi:10.1161/circulationaha.109.883843 · Cited by 513
Self-citationIncreased Sympathetic Nerve Activity in Pulmonary Artery Hypertension
Velez-Roa, S., Ciarka, A., Najem, B., Vachiery, J.-L., Naeije, R., & van de Borne, P. (2004) · Circulation · doi:10.1161/01.cir.0000140724.90898.d3 · Cited by 443
Survival in primary pulmonary hypertension. Validation of a prognostic equation.
Sandoval, J., Bauerle, O., Palomar, A., Gómez, A., Martínez-Guerra, M. L., Beltrán, M., & Guerrero, M. L. (1994) · Circulation · doi:10.1161/01.cir.89.4.1733 · Cited by 366
Oka, M., Homma, N., Taraseviciene-Stewart, L., Morris, K. G., Kraskauskas, D., Burns, N., Voelkel, N. F., & McMurtry, I. F. (2007) · Circulation Research · doi:10.1161/01.res.0000261658.12024.18 · Cited by 331
Self-citationProvencher, S., Herve, P., Jais, X., Lebrec, D., Humbert, M., Simonneau, G., & Sitbon, O. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.10.013 · Cited by 312
Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., Michl, K., et al. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.08.023 · Cited by 309
A decade of discoveries in cardiac biology
Olson, E. N. (2004) · Nature Medicine · doi:10.1038/nm0504-467 · Cited by 291
Toward transcriptional therapies for the failing heart: chemical screens to modulate genes
McKinsey, T. A., & Olson, E. N. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200524144 · Cited by 288
Incidence and clinical relevance of supraventricular tachyarrhythmias in pulmonary hypertension
Tongers, J., Schwerdtfeger, B., Klein, G., Kempf, T., Schaefer, A., Knapp, J.-M., Niehaus, M., Korte, T., & Hoeper, M. M. (2007) · American Heart Journal · doi:10.1016/j.ahj.2006.09.008 · Cited by 277
Fiedler, B., Lohmann, S. M., Smolenski, A., Linnemüller, S., Pieske, B., Schröder, F., Molkentin, J. D., Drexler, H., & Wollert, K. C. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162100799 · Cited by 276
The Cancer Paradigm of Severe Pulmonary Arterial Hypertension
Rai, P. R., Cool, C. D., King, J. A. C., Stevens, T., Burns, N., Winn, R. A., Kasper, M., & Voelkel, N. F. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200709-1369pp · Cited by 258
Self-citationOsteopontin Expression Is Required for Myofibroblast Differentiation
Lenga, Y., Koh, A., Perera, A. S., McCulloch, C. A., Sodek, J., & Zohar, R. (2008) · Circulation Research · doi:10.1161/circresaha.107.160408 · Cited by 241
Herron, T. J., & McDonald, K. S. (2002) · Circulation Research · doi:10.1161/01.res.0000022879.57270.11 · Cited by 203
Outcome after Cardiopulmonary Resuscitation in Patients with Pulmonary Arterial Hypertension
HOEPER, M. M., GALIÈ, N., MURALI, S., OLSCHEWSKI, H., RUBENFIRE, M., ROBBINS, I. M., FARBER, H. W., MCLAUGHLIN, V., SHAPIRO, S., PEPKE-ZABA, J., et al. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.3.200109-0130c · Cited by 171
Burley, D. S., Ferdinandy, P., & Baxter, G. F. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707409 · Cited by 167
Impaired Stroke Volume Response to Exercise in Pulmonary Arterial Hypertension
Holverda, S., Gan, C. T., Marcus, J. T., Postmus, P. E., Boonstra, A., & Noordegraaf, A. V. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.01.048 · Cited by 149
Buermans, H. P. J., Redout, E. M., Schiel, A. E., Musters, R. J. P., Zuidwijk, M. J., Eijk, P. P., van Hardeveld, C., Kasanmoentalib, S., Visser, F. C., Ylstra, B., et al. (2005) · Physiological Genomics · doi:10.1152/physiolgenomics.00185.2004 · Cited by 147
Mochizuki, M., Yano, M., Oda, T., Tateishi, H., Kobayashi, S., Yamamoto, T., Ikeda, Y., Ohkusa, T., Ikemoto, N., & Matsuzaki, M. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.01.064 · Cited by 137
Davis, M. E., Richards, M., Nicholls, M. G., Yandle, T. G., FRAMPTON, C. M. A., & Troughton, R. W. (2006) · Circulation · doi:10.1161/circulationaha.105.567727 · Cited by 134
Handoko, M. L., de Man, F. S., Allaart, C. P., Paulus, W. J., Westerhof, N., & Noordegraaf, A. V. (2010) · European Respiratory Review · doi:10.1183/09059180.00007109 · Cited by 123
Estacio, R. O., & Schrier, R. W. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00750-4 · Cited by 122
Sympathetic neuronal regulation of the heart in aging and heart failure
Kaye, D. M., & Esler, M. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.02.012 · Cited by 121
Cardiac Sympathetic Rejuvenation: A Link Between Nerve Function and Cardiac Hypertrophy
Kimura, K., Ieda, M., Kanazawa, H., Yagi, T., Tsunoda, M., Ninomiya, S.-I., Kurosawa, H., Yoshimi, K., Mochizuki, H., Yamazaki, K., et al. (2007) · Circulation Research · doi:10.1161/01.res.0000269828.62250.ab · Cited by 109
Importance of beta blockade in the therapy of serious ventricular arrhythmias
Reiter, M. J., & Reiffel, J. A. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00468-8 · Cited by 104
Transthyretin V122I in African Americans With Congestive Heart Failure
Buxbaum, J. N., Jacobson, D. R., Tagoe, C. E., Alexander, A. A., Kitzman, D. W., Greenberg, B., Thaneemit-Chen, S., & Lavori, P. W. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.01.042 · Cited by 92
Mito, S., Ozono, R., Oshima, T., Yano, Y., Watari, Y., Yamamoto, Y., Brydun, A., Igarashi, K., & Yoshizumi, M. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.102566 · Cited by 83
Kiriazis, H., Wang, K. K., Xu, Q., Gao, X., Ming, Z., Su, Y. R., Moore, X., Lambert, G. W., Gibbs, M. E., Dart, A. M., et al. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707622 · Cited by 54
Hsu, S., Nagayama, T., Koitabashi, N., Zhang, M., Zhou, L., Bedja, D., Gabrielson, K. L., Molkentin, J. D., Kass, D. A., & Takimoto, E. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn324 · Cited by 52
Leineweber, K., Brandt, K., Wludyka, B., Beilfuss, A., Pönicke, K., Heinroth‐Hoffmann, I., & Brodde, O. (2002) · Circulation Research · doi:10.1161/01.res.0000045088.59360.b7 · Cited by 50
Novel Role for Osteopontin in Cardiac Fibrosis
Zahradka, P. C. (2008) · Circulation Research · doi:10.1161/circresaha.107.170555 · Cited by 50
Role of the Natriuretic Peptide System in Cardiorenal Protection
McFarlane, S. I., Winer, N., & Sowers, J. R. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.22.2696 · Cited by 49
Carvedilol prevents severe hypertensive cardiomyopathy and remodeling
Barone, F. C., Campbell, W. G., Nelson, A. H., & Feuerstein, G. Z. (1998) · Journal of Hypertension · doi:10.1097/00004872-199816060-00019 · Cited by 45
Carvedilol Enhances Atrial and Brain Natriuretic Peptide mRNA Expression and Release in Rat Heart
Ohta, Y., Watanabe, K., Nakazawa, M., Yamamoto, T., Ma, M., Fuse, K., 伊藤, 正., Hirono, S., Tanabe, N., Hanawa, H., et al. (2000) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200000006-00006 · Cited by 36
Impairment of Myocardial Angiogenic Response in the Absence of Osteopontin
Zhao, X., Johnson, J. N., Singh, K., & Singh, M. (2007) · Microcirculation · doi:10.1080/10739680601139369 · Cited by 32
Cited by
Pulmonary arterial hypertension: pathogenesis and clinical management
Thenappan, T., Ormiston, M. L., Ryan, J. J., & Archer, S. L. (2018) · BMJ · doi:10.1136/bmj.j5492 · Cited by 998
Right Heart Adaptation to Pulmonary Arterial Hypertension
Vonk-Noordegraaf, A., Haddad, F., Chin, K. M., Forfia, P. R., Kawut, S. M., Lumens, J., Naeije, R., Newman, J., Oudiz, R. J., Provencher, S., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.027 · Cited by 982
Self-citationRyan, J. J., & Archer, S. L. (2014) · Circulation Research · doi:10.1161/circresaha.113.301129 · Cited by 471
The monocrotaline model of pulmonary hypertension in perspective
Gomez-Arroyo, J. G., Farkas, L., Alhussaini, A. A., Farkas, D., Kraskauskas, D., Voelkel, N. F., & Bogaard, H. J. (2012) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00212.2011 · Cited by 424
Self-citationMocumbi, A., Humbert, M., Saxena, A., Jing, Z.-C., Sliwa, K., Thienemann, F., Archer, S. L., & Stewart, S. (2024) · Nature Reviews Disease Primers · doi:10.1038/s41572-023-00486-7 · Cited by 370
Metadata
- Authors
- Bogaard, H. J., Natarajan, R., Mizuno, S., Abbate, A., Chang, P. J., Chau, V. Q., Hoke, N. N., Kraskauskas, D., Kasper, M., Salloum, F. N., & Voelkel, N. F.
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-09-01
- Volume
- 182
- Issue
- 5
- Pages
- 652-660
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W2025717255
- Cited by
- 287
- References
- 48
- FWCI
- 14.27
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.